Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$10.18 - $26.64 $1.93 Million - $5.05 Million
-189,494 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$18.57 - $35.68 $401,631 - $771,687
-21,628 Reduced 10.24%
189,494 $5.05 Million
Q1 2021

May 14, 2021

SELL
$31.0 - $55.72 $69,130 - $124,255
-2,230 Reduced 1.05%
211,122 $7.33 Million
Q4 2020

Feb 02, 2021

BUY
$37.09 - $48.97 $788,607 - $1.04 Million
21,262 Added 11.07%
213,352 $7.91 Million
Q3 2020

Nov 05, 2020

BUY
$40.47 - $45.5 $336,791 - $378,651
8,322 Added 4.53%
192,090 $7.9 Million
Q2 2020

Aug 12, 2020

BUY
$32.57 - $42.83 $291,762 - $383,671
8,958 Added 5.12%
183,768 $7.45 Million
Q1 2020

May 12, 2020

SELL
$23.3 - $45.96 $37,280 - $73,536
-1,600 Reduced 0.91%
174,810 $6.08 Million
Q4 2019

Jan 27, 2020

BUY
$34.58 - $48.06 $1.12 Million - $1.56 Million
32,506 Added 22.59%
176,410 $7.57 Million
Q3 2019

Oct 31, 2019

BUY
$36.98 - $48.45 $1.04 Million - $1.36 Million
28,012 Added 24.17%
143,904 $5.32 Million
Q2 2019

Aug 15, 2019

BUY
$35.13 - $55.53 $400,200 - $632,597
11,392 Added 10.9%
115,892 $5.24 Million
Q1 2019

May 03, 2019

SELL
$42.83 - $59.91 $72,811 - $101,847
-1,700 Reduced 1.6%
104,500 $5.68 Million
Q4 2018

Feb 08, 2019

BUY
$37.97 - $60.16 $64,549 - $102,272
1,700 Added 1.63%
106,200 $4.92 Million
Q3 2018

Nov 13, 2018

SELL
$56.3 - $67.25 $1.15 Million - $1.37 Million
-20,356 Reduced 16.3%
104,500 $6.35 Million
Q2 2018

Aug 15, 2018

SELL
$44.9 - $64.95 $441,995 - $639,367
-9,844 Reduced 7.31%
124,856 $7.82 Million
Q1 2018

May 11, 2018

SELL
$45.35 - $61.65 $294,775 - $400,725
-6,500 Reduced 4.6%
134,700 $6.22 Million
Q4 2017

Feb 06, 2018

BUY
$41.95 - $60.1 $1.94 Million - $2.78 Million
46,300 Added 48.79%
141,200 $6.69 Million
Q3 2017

Nov 15, 2017

BUY
$33.4 - $53.9 $3.17 Million - $5.12 Million
94,900
94,900 $5.11 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.